LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis
J Quan, X Pan, L Zhao, Z Li, K Dai, F Yan… - OncoTargets and …, 2018 - Taylor & Francis
Background Bladder cancer is one of the most common urinary malignancies, and has a
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …
high recurrence rate and poor outcomes. In order to identify novel diagnostic and prognostic …
[HTML][HTML] Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer
W Duan, L Du, X Jiang, R Wang, S Yan, Y Xie, K Yan… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Accumulating evidence indicates that long non-coding RNAs (lncRNAs) play important roles
in tumorigenesis and progression. We aimed to identify a panel of lncRNAs for the diagnosis …
in tumorigenesis and progression. We aimed to identify a panel of lncRNAs for the diagnosis …
[HTML][HTML] Biological functions and clinical significance of long noncoding RNAs in bladder cancer
Y Zhang, X Chen, J Lin, X Jin - Cell death discovery, 2021 - nature.com
Bladder cancer (BCa) is one of the 10 most common cancers with high morbidity and
mortality worldwide. Long noncoding RNAs (lncRNAs), a large class of noncoding RNA …
mortality worldwide. Long noncoding RNAs (lncRNAs), a large class of noncoding RNA …
Cell‐free lncRNA expression signatures in urine serve as novel non‐invasive biomarkers for diagnosis and recurrence prediction of bladder cancer
L Du, W Duan, X Jiang, L Zhao, J Li… - Journal of cellular …, 2018 - Wiley Online Library
Cell‐free long non‐coding RNAs (lncRNAs) are stably present in urine and can serve as
non‐invasive biomarkers for cancer. We aimed to identify signatures of lncRNAs in urine for …
non‐invasive biomarkers for cancer. We aimed to identify signatures of lncRNAs in urine for …
Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers
D Terracciano, M Ferro, S Terreri, G Lucarelli… - Translational …, 2017 - Elsevier
Several reports over the last 10 years provided evidence that long noncoding RNAs
(lncRNAs) are often altered in bladder cancers. lncRNAs are longer than 200 nucleotides …
(lncRNAs) are often altered in bladder cancers. lncRNAs are longer than 200 nucleotides …
[HTML][HTML] An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer
P Lian, Q Wang, Y Zhao, C Chen, X Sun, H Li… - Aging (Albany …, 2019 - ncbi.nlm.nih.gov
Backgroud: Bladder cancer (BLCA) is one of the most fatal types of cancer worldwide.
However, there are limited methods for us to provide a prognostic prediction of BLCA …
However, there are limited methods for us to provide a prognostic prediction of BLCA …
Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer
T Chen, W Xie, L Xie, Y Sun, Y Zhang, Z Shen… - Biochemical and …, 2015 - Elsevier
Long noncoding RNAs (lncRNAs) have been implicated playing important roles in human
urologic cancers. In the present study, microarray analysis was initially performed to screen …
urologic cancers. In the present study, microarray analysis was initially performed to screen …
[HTML][HTML] Long noncoding RNA expression signatures of bladder cancer revealed by microarray
YP Zhu, XJ Bian, DW Ye, XD Yao… - Oncology …, 2014 - spandidos-publications.com
Dysregulation of long noncoding RNAs (lncRNAs) has been regarded as a primary feature
of several human cancers. However, the genome‑wide expression and functional …
of several human cancers. However, the genome‑wide expression and functional …
[HTML][HTML] Integrated analysis of a competing endogenous RNA network reveals key lncRNAs as potential prognostic biomarkers for human bladder cancer
N Zhu, J Hou, Y Wu, J Liu, G Li, W Zhao, G Ma, B Chen… - Medicine, 2018 - journals.lww.com
Human bladder cancer (BCa) is one of the most commonly diagnosed malignancies
worldwide. It has high recurrence rates and low-grade malignancy, thus representing an …
worldwide. It has high recurrence rates and low-grade malignancy, thus representing an …
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
相关搜索
- recurrence prediction bladder cancer
- meta analysis bladder cancer
- rna expression bladder cancer
- lncrna panel bladder cancer
- overall survival bladder cancer
- biological functions bladder cancer
- clinical significance bladder cancer
- rna network integrated analysis
- tumor stage bladder cancer
- rna signature bladder cancer
- rna network bladder cancer
- integrated analysis bladder cancer